The above free vintage image of a laboratory is courtesy of iStock and Google Images.

Health Friday is a series devoted to information regarding Big Pharma, vaccines, general health, and associated topics.

There are Important Notifications by our host, Wolf Moon; the Rules of our late, good Wheatie; and, certain caveats from Yours Truly, of which readers should be aware. They are linked here. NOTE: Yours Truly has checked today’s offering for any AI-generated content. To the best of her knowledge and belief, there is none. If readers wish to post anything in the discussion thread for today’s post that is AI-generated, they must cite their source. Thank you.

Due to the nature of today’s topic, there will be two separate posts. Part One, today’s offering, starts here: https://www.hhs.gov/press-room/hhs-nih-announces-generation-gold-standard.html, “HHS, NIH Launch Next-Generation Universal Vaccine Platform for Pandemic-Prone Viruses”, 1 May 2025. Please see the following screenshots from the announcement:

To unpack the announcement, Yours Truly will begin with a 2016 document from the EPA regarding beta-propiolactone, aka BPL (as in BPL-1357): https://www.epa.gov/sites/default/files/2016-09/documents/beta-propiolactone.pdf. Please see the following screenshots from this document:

Notice the risks associated with inhalation of beta-propiolactone (which is being used in the development and testing of the “new Gold Standard” intranasal version of the “new Universal Pandemic Vaccine”, BPL-1357.)

Note the language regarding irritations of various types; of damage to the corneas; convulsions; and “extreme acute toxicity.”

Note the language about cancer being induced in lab rats and mice by the use of beta-propiolactone, but no information being available regarding the inducement of cancer in humans by the use of beta-propiolactone.

The funds for Generation Gold Standard, in the amount of $500 million dollars, will come from reallocation of monies within BARDA (Biomedical Advanced Research and Development Authority: https://www.fiercebiotech.com/biotech/hhs-unveils-500m-universal-vaccine-initiative-calls-biden-era-covid-vax-accelerator, “HHS unveils $500M universal vaccine initiative, calls Biden-era COVID vax accelerator ‘wasteful'”, 1 May 2025. Please see the screenshots from this article, below:

Both Dr. Memoli and Dr. Taubenberger have been with the NIH / NIAID for years. Also, note the tiny subject pool of 45 adult subjects in the Phase 1 study of BPL-1357.

On a “tangential point”, there is this FDA announcement of 10 April 2025: https://www.fda.gov.media/186092/download, “Roadmap to Reducing Animal Testing in Preclinical Safety Studies”, by new FDA Director Dr. Marty Makary. Sasha Latypova analyzed the announcement here: https://sashalatypova.substack.com/p/you-didnt-want-that-mrna-vax-tested, “You didn’t want that mRNA vax tested only on 8 mice? Marty Makary, FDA, has a solution — no more mice!”, 28 April 2025.

That’s right. Dr. Makary wants to reduce, then end, animal testing for vaccines in the preclinical stage, and to substitute testing them instead by using in silico models; then, to move to human subject testing; and, even to NOT have ANY human subject clinical trials at all in “certain circumstances.” Please see the screenshots below from the Latypova article:

Yours Truly understands that the use of animals in lab experiments must be done in the most humane manner possible — no more of the “Fauci tortured Beagles” situations. However, one is of the opinion that there is a place for using animals in lab experiments — to study physical reactions and/or reproductive issues related to the drug or injectable under investigation before human tests begin: something that an in silico model or an AI model cannot do. And, the part about no clinical trials at all in “certain circumstances”:

Note: the red text in the screenshots above link to other articles and information from the Latypova article. Also, recall that Ms. Latypova worked in medical and pharmaceutical techology for years before retiring from the field.

This is the same Dr. Marty Makary who recommended that pregnant women get COVID-19 “vaccinated”:

To finish today’s Part One offering, Yours Truly presents the involvement of United States Defense Department in the use of the “AFLQ adjuvant” that is going to be tested in clinical trials for BPL-1357: https://hivresearch.org/hiv-research/alf-adjuvants. This is the United States military research program into “Military HIV.” This article had a link that led to the following press release by the United States Army, from 2021: https://wrair.health.mil/News-Media/Press-Releases/Article/3166852/phase-1-clinical-trial-of-wrair-developed-covid-19-vaccine-begins/, 5 April 2021. The clinical trial is NCT04784767, that began with 29 subject enrollees on 5 April 2021, and had an “Estimated Study Completion Date” of 30 October 2023 (https://clinicaltrials.gov/study/NCT04784767.) The title of the clinical trial: “SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine with ALFQ Adjuvant for Prevention of COVID-19 in Healthy Adults.” Below is a screenshot of the WRAIR article (WRAIR stands for Walter Reed Army Institute of Research):

Note the statement by Dr. Modjarrad that this “US Army COVID-19 Vaccine” would “pave the way for a universal vaccine to protect against not only the current virus, but also counter future variants…” — “universal vaccine” — sound familiar? “Who is driving this bus?” comes to mind.

To be continued in Part Two.

THERE. MUST. BE. JUSTICE.

Peace, Good Energy, Respect: PAVACA